Manufacturing small batches of biopharmaceuticals on demand
Portable biopharmaceutical drug manufacturers could be the future method of producing the drugs on demand for outbreaks of disease...
List view / Grid view
Portable biopharmaceutical drug manufacturers could be the future method of producing the drugs on demand for outbreaks of disease...
Researchers have released data on a clinical trial using specific inhalers and oral capsules to deliver cannabinoids to participants...
A report has suggested that the biosimilars market growth will increase at a CAGR of 34.2 percent over the course of the period analysed...
Tannin acid injections to treat cardiovascular disease may avoid the need for surgery, according to research from Korea...
The particle size of Active Pharmaceutical Ingredients (API) has a significant effect on a drug product’s manufacturability and performance. With respect to manufacturability, particle size can affect compatibility, flowability and blend uniformity; with respect to product performance it can affect solubility, dissolution, and bioavailability.
Even with the rise of rapid microbiological methods, most environmental monitoring applications are undertaken using culture media, with many alternative methods also being growth-based. This makes the selection, control and release of culture media an area of great importance, given that the quality of the culture media underpins the environmental…
A US perspective on how pharma companies are preparing for Brexit, overcoming disinfectant residues with culture media neutralisers, unlocking the potential of new technology in biopharma, and much more in this issue of European Pharmaceutical Review.
The crystal structure was found to have a half-life of 24 hours and could last in the bloodstream for more than 96 hours...
A drug currently in trials for Parkinson's disease has shown promise in treating heart failure, without the risk of dangerous side effects...
The onset of side effects of a common cancer treatment, anti-PD-1 therapy can be identified up to 3 years after treatment...
A novel drug based on capsaicin caused long-term weight loss and improved metabolic health in mice eating a high-fat diet...
The global clinical microbiology market is projected to reach USD 4.95bn by 2023 from USD 3.63bn in 2018, growing at a CAGR of 6.4% from 2018 to 2023.
Two companies will work closely together on future development, distribution, promotion, access, marketing and sales of Invokana (canagliflozin) for type 2 diabetes...
Novel regimen enables physicians to fully dose up to two months of Aristada treatment on day one...
A study shows low-dose aspirin may aid removal of harmful amyloid plaque in the brain...